Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/ACB stock hub

TSX/ACB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/ACBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

274.3M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/ACB

In the news

Latest news · TSX/ACB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-15.5

P25 -121.5P50 -40.9P75 0.5

ROIC-10.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/ACB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

CAD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	1,073
Enterprise value	CAD 298.4M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA05156X8504
Last refreshed	2026-05-10
Market cap	CAD 274.3M
Price	CAD 4.64
Price currency	CAD
Rev Per Employee	347,733.46x
Sector	Healthcare
Sic	2834
Symbol	tsx/ACB
Website	https://www.auroramj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.61%
EV Earnings	-3.55x
EV/FCF	-9.54x
EV/Sales	0.8x
FCF yield	-11.4%
P/B ratio	0.48x
P/S ratio	0.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-15.34%
EBITDA Margin	-8.77%
Gross margin	36.03%
Gross Profit	CAD 134.4M
Gross Profit Growth	-34.86%
Gross Profit Growth Q	-37.79%
Net Income	CAD -84M
Net Income Growth Q	-93.63%
Net Income Growth Years	3%
Pretax Margin	-21.84%
Profit Margin	-22.51%
Profit Per Employee	CAD -78,277
Profitable Years	1
ROA	-4.36
ROCE	-9.09
ROE	-15.51
ROIC	-10.11
Roic5y	-14.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-22.06%
Cagr1y	-26.83%
Cagr3y	-19.21%
Cagr5y	-46.73%
EPS Growth Q	-94.69
EPS Growth Years	3
FCF Growth Q	-54.06%
OCF Growth Q	-41.06%
Revenue Growth	16.54x
Revenue Growth Q	6.8x
Revenue Growth Quarters	7x
Revenue Growth Years	3x
Revenue Growth3 Y	20.81x
Revenue Growth5 Y	6.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.45
Assets	CAD 775.3M
Cash	CAD 108.5M
Current Assets	CAD 445.8M
Current Liabilities	CAD 145.9M
Debt	CAD 101M
Debt Equity	CAD 0.18
Debt FCF	CAD -3.23
Equity	CAD 567.8M
Interest Coverage	-6.64
Liabilities	CAD 207.5M
Long Term Assets	CAD 329.5M
Long Term Liabilities	CAD 61.5M
Net Cash	CAD 7.5M
Net Cash By Market Cap	CAD 2.72
Net Cash Growth	-3.56%
Net Debt Equity	CAD -0.01
Tangible Book Value	CAD 475.1M
Tangible Book Value Per Share	CAD 8.38
WACC	10.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	0.99
Net Working Capital	CAD 259.2M
Quick ratio	1.05
Working Capital	CAD 299.9M
Working Capital Turnover	CAD 1.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-91.73%
1Y total return	-26.81%
200-day SMA	6.06
3Y total return	-47.27%
50-day SMA	4.77
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.71%
All Time High	1,948.8
All Time High Change	-99.76%
All Time High Date	2018-10-16
All Time Low	3.84
All Time Low Change	20.83%
All Time Low Date	2024-03-14
ATR	0.22
Beta	1.33
Beta1y	2.01
Beta2y	1.72
Ch YTD	-19.58
High	4.75
High52	9.33
High52 Date	2025-10-09
High52ch	-50.27%
Low	4.63
Low52	4.29
Low52 Date	2026-03-30
Low52ch	8.29%
Ma50ch	-2.64%
Price vs 200-day SMA	-23.41%
RSI	46.56
RSI Monthly	35.73
RSI Weekly	39.68
Sharpe ratio	-0.17x
Sortino ratio	-0.17
Total Return	-2.97%
Tr YTD	-19.58
Tr1m	-1.07%
Tr1w	-1.69%
Tr3m	-2.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -57.2M
Operating Income Growth Q	-93.29
Operating margin	-15.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,838,663%
Net Borrowing	-1,899,000
Shares Insiders	0.49%
Shares Institutions	11.5%
Shares Out	59,126,604
Shares Qo Q	1.54%
Shares Yo Y	2.97%
Short Float	3.33%
Short Shares	3.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -44M
Average Volume	550,690.25x
Bv Per Share	9.46
CAPEX	CAD -21.7M
Ch10y	-92.03
Ch1m	-1.07
Ch1w	-1.69
Ch1y	-26.81
Ch3m	-2.73
Ch3y	-47.27
Ch5y	-95.71
Ch6m	-27.27
Change	-1.28%
Change From Open	-1.49
Close	4.7
Days Gap	0.21
Depreciation Amortization	24,491,000
Dollar Volume	1,230,537.3
Earnings Date	2026-06-17
EBIT	CAD -57.2M
EBITDA	CAD -32.7M
EPS	CAD -1.5
F Score	2
FCF	CAD -31.3M
FCF EV Yield	-10.48x
FCF Per Share	CAD -0.53
Financing CF	-673,000
Fiscal Year End	March
Founded	2,013
Goodwill	25,639,000
Income Tax	CAD 10M
Investing CF	-71,165,000
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Last Split Date	2024-02-20
Last Split Type	Reverse
Ma150	5.77
Ma150ch	-19.54%
Ma20	4.8
Ma20ch	-3.31%
Net CF	-76,262,000
Next Earnings Date	2026-06-17
Open	4.71
Position In Range	8.33
Ppne	259,110,000
Price Date	2026-05-08
Ptbv Ratio	0.58
Relative Volume	0.48x
Revenue	373,118,000x
SBC By Revenue	3.42x
Share Based Comp	12,772,000
Tax By Revenue	2.69x
Tr6m	-27.27%
Volume	265,202
Z Score	-9.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/ACB pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/ACB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/ACB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

+3.3%

Float sold short by bearish positioning

Y/Y dilution

+3.0%

Negative means the company is buying back shares.

Technical

TSX/ACB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.6

Neutral momentum band

Price vs 200-day MA

-23.4%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

-0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/ACB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/ACB stock rating?

tsx/ACB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/ACB analysis?

The full report lives at /stocks/tsx/ACB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/ACB?

The latest report frames tsx/ACB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/ACB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.